These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 7103524)
1. Etretinate therapy causes increases in lipid levels in patients with psoriasis. Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524 [TBL] [Abstract][Full Text] [Related]
2. Glucose and insulin responses are improved in patients with psoriasis during therapy with etretinate. Ellis CN; Kang S; Vinik AI; Grekin RC; Cunningham WJ; Voorhees JJ Arch Dermatol; 1987 Apr; 123(4):471-5. PubMed ID: 3548599 [TBL] [Abstract][Full Text] [Related]
3. [Changes in serum lipid fractions as a side effect of oral retinoids]. Gollnick H; Luley C; Schwartzkopff W; Orfanos CE Z Hautkr; 1982 Sep; 57(17):1255-67. PubMed ID: 6216675 [TBL] [Abstract][Full Text] [Related]
4. Etretin therapy for severe psoriasis. Evaluation of initial clinical responses. Kingston TP; Matt LH; Lowe NJ Arch Dermatol; 1987 Jan; 123(1):55-8. PubMed ID: 2948451 [TBL] [Abstract][Full Text] [Related]
5. Serum lipid changes during acitretin (etretin) treatment of psoriasis and palmo-plantar pustulosis. Vahlquist C; Selinus I; Vessby B Acta Derm Venereol; 1988; 68(4):300-5. PubMed ID: 2459874 [TBL] [Abstract][Full Text] [Related]
6. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation. Frati C; Bevilacqua L; Apostolico V Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820 [TBL] [Abstract][Full Text] [Related]
7. The influence of 'Tigason' (Ro 10-9359) on the serum lipoproteins in man. Michaëlsson G; Bergqvist A; Vahlquist A; Vessby B Br J Dermatol; 1981 Aug; 105(2):201-5. PubMed ID: 7284249 [TBL] [Abstract][Full Text] [Related]
8. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study. Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606 [TBL] [Abstract][Full Text] [Related]
9. [Serum triglycerides and cholesterin in patients with skin diseases during oral treatment with aromatic retinoid (author's transl)]. Gollnick H; Orfanos CE Z Hautkr; 1981 Sep; 56(18):1183-96. PubMed ID: 7293303 [TBL] [Abstract][Full Text] [Related]
10. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients. Bjerke JR; Geiger JM Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847 [TBL] [Abstract][Full Text] [Related]
11. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894 [TBL] [Abstract][Full Text] [Related]
12. Oral retinoid for psoriasis. A report of a double blind study. Pettit JH Acta Derm Venereol Suppl (Stockh); 1979; 59(85):133-6. PubMed ID: 393035 [TBL] [Abstract][Full Text] [Related]
18. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate. Meffert H; Sönnichsen N Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846 [No Abstract] [Full Text] [Related]
19. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia. Dujovne CA; Zavoral JH; Rowe E; Mendel CM; Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363 [TBL] [Abstract][Full Text] [Related]
20. [Characteristics of the lipid transport system in psoriasis]. Torkhovskaia TI; Fortinskaia ES; Ivanova LI; Nikitina NA; Zakharova TS; Kochetova MM; Kliuchnikova ZhI; Sharapova GIa; Khalilov EM Vopr Med Khim; 2002; 48(3):297-303. PubMed ID: 12243089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]